Based on the Wall Street analyst consensus for 40 of FPHAX’s holdings.
FPHAX Analyst Price Target
Average Price Target
$46.51▲(20.50% Upside)
Based on Wall Street analyst 12-month price targets for 40 of Fidelity Select Pharmaceuticals’s holdings in the last 3 months. The average price target is $46.51 with a high forecast of $57.53 and a low forecast of $31.85. The average price target represents a 20.50% change from the last price of $38.60.
Past 12 Months12 Month ForecastFeb2026Nov2026
High$57.53
Average$46.51
Low$31.85
Past 12 Months12 Month Forecast$28$35.5$43$50.5$58Feb2026May2026Aug2026Nov2026Nov2027
What is FPHAX’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 40 of FPHAX’s holdings, Fidelity Select Pharmaceuticals’s 12-month average price target is $46.51.
What is FPHAX’s upside potential, based on the analysts’ average price target?
FPHAX’s average price target of $46.51 represents a 20.50% upside from its last price of $38.60.
Is FPHAX a Buy, Sell or Hold?
Fidelity Select Pharmaceuticals has a consensus rating of Moderate Buy, based on the analyst consensus for 40 of FPHAX’s holdings: 36 rated Buy, 4 rated Hold and 0 rated Sell.
What is Fidelity Select Pharmaceuticals’s price target?
The average price target for Fidelity Select Pharmaceuticals is $46.51, based on Wall Street analyst 12-month price targets for 40 of FPHAX’s holdings, issued in the past 3 months. The highest price target is $57.53 and the lowest is $31.85. The average price target represents a 20.50% increase from the last price of $38.60.
How can I buy shares of FPHAX?
You can buy shares of FPHAX through a brokerage account. Compare brokers on our Best Online Brokers page.